Swedish Macrolane Registry

NCT01145235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2022-08-25

No results posted yet for this study

Summary

A Registry to monitor long term safety in female subjects after treatment with Macrolane VRF20 and/or MacrolaneT VRF30 in the breasts.

Conditions

  • Breast Augmentation

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145235 on ClinicalTrials.gov